lncRNA TUG1 was used as a non-invasive, cost-effective, and complementary biomarker in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma (Mai et al. 2020). This evidence concerns the gene TUG1 and hepatocellular carcinoma.